Table 2 Meta-analysis results of apatinib combined with radiotherapy in the treatment of PC
| Â | Â | Â | Heterogeneity test | Meta-analysis of the test results | ||||
|---|---|---|---|---|---|---|---|---|
Prevalence of hepatic and renal damage | Number of studies | Sample capacity | P | I2 | Effect model | MD/OR | 95% CI | P |
Radiation-induced inflammation | 5 | 308 | 0.94 | 0% | Fixed | 1.30 | (0.68, 2.49) | 0.43 |
Proteinuria | 5 | 308 | 0.98 | 0% | Fixed | 1.31 | (0.62, 2.73) | 0.48 |
Nausea and vomiting | 7 | 428 | 0.64 | 0% | Fixed | 1.01 | (0.64, 1.58) | 0.97 |
Thrombocytopenia | 2 | 120 | 0.07 | 69% | Random | 0.73 | (0.04, 12.88) | 0.83 |
Leukopenia | 3 | 187 | 0.12 | 54% | Random | 0.57 | (0.13, 2.46) | 0.45 |
Outcome indicators | 4 | 248 | 0.95 | 0% | Fixed | 1.09 | (0.58, 2.04) | 0.79 |
Hypertension | 2 | 120 | 0.02 | 83% | Random | 0.24 | (0.00, 22.29) | 0.54 |